Verisma Secures Golub Financing for Health Data Expansion

The same patient record can support a care decision, a quality report and a request to release information. Verisma is building its business across those different jobs, asking healthcare organizations to treat the movement and preservation of information as a continuing operating responsibility.

The Alpharetta, Georgia company announced senior-secured financing from Golub Capital on October 29, 2026, including a delayed-draw term loan facility. The undisclosed financing supports technology development and potential acquisitions at the NewSpring-backed company, putting private credit behind a provider of health information lifecycle management technology and services.

What Golub's financing supports at Verisma

Verisma's announcement describes a financing for an established operating platform, with both product investment and acquisition opportunities in view. CEO Marty McKenna connects that expansion to healthcare organizations' growing use of information management in care coordination, quality reporting and reimbursement. The commercial ambition is to participate in more of the work surrounding a record, from retrieving it to making it useful to the next team.

The financing amount, pricing, maturity and amount drawn were not disclosed. A delayed-draw facility provides a mechanism for future borrowing under its terms; the announcement gives readers no basis to put a dollar figure on cash received. Debt is the appropriate deal classification, while NewSpring's existing private equity backing describes a separate relationship.

Golub Capital specializes in financing companies backed by private equity sponsors. Its Co-President and Co-Head of Sponsor Finance, Spyro Alexopoulos, represents the lender in the announcement. NewSpring is the continuing sponsor supporting a company with a record of combining software, service teams and acquisitions.

That pairing is useful context for the funding story. Verisma's route to growth includes adding capabilities to a business already serving healthcare institutions, with acquisition integration becoming part of the assignment alongside product engineering. The announcement identifies the intended uses of capital but names no next acquisition target or completion timetable.

Why the document's next destination matters

Verisma's Inbound Document Intelligence product describes a sequence that starts with receiving, identifying and matching documents to a patient chart. It also supports follow-up actions and extracting information for quality reporting. Those capabilities place the service closer to the moment when an administrative handoff can influence whether somebody has the information needed to continue care.

The company routes exceptions to client-defined procedures back to human reviewers. That design gives healthcare buyers a concrete responsibility to examine: which rules govern an automated action, how an exception is recognized and where it lands for review. A faster intake process is useful only alongside a workable way to handle the documents that need more attention.

Founder and Executive VP Andy McManus remains part of Verisma's current leadership. The company-managed profile dates the business to 2002, placing the new financing within a longer service history rather than presenting AI as the company's starting point. McKenna's background includes healthcare technology roles at Allscripts Analytics, dbMotion and GE, experience relevant to selling into institutions with existing systems and operating routines.

For the customer, the purchase reaches beyond a document classifier. It includes the procedure for getting information into the chart, telling the right staff and handling work that departs from the agreed process. As Verisma invests in the platform, the people maintaining those procedures remain part of what the institution is buying.

The records outside the standard integration

Chief Technology & Product Officer Anupriyo Chakravarti has offered a useful explanation of Verisma's access strategy. In a June 2026 article on interoperability, he describes the gap between connecting common electronic health record systems and retrieving everything a particular request requires. Less common applications and archived information can still matter to the person assembling the record.

That distinction broadens the competitive question. A healthcare buyer comparing suppliers needs to understand the coverage of its actual information environment, including older systems and unusual requests. Counting integrations offers one view of the product; the institution also has to establish how the supplier deals with the remaining material.

Verisma's Olah data archiving platform addresses another part of that environment. The company describes preserving structured and unstructured information, maintaining search and access, and supporting the retirement of legacy applications. The operational proposition is that the hospital can change its technology estate while keeping historical information available for clinical, financial and administrative work.

These are vendor-described capabilities, rather than independently established improvements in clinical outcomes or hospital finances. Their strategic relevance lies in the connected scope: retrieval, release, coordination and retention place several information tasks within Verisma's reach. A buyer considering that breadth still needs to examine access controls, implementation obligations and the service arrangement around each task.

An acquisition strategy inherits the customer's history

NewSpring Healthcare funded Verisma's combination with ScanSTAT in April 2023, bringing together release-of-information technology and service capabilities. That history helps explain the place acquisitions hold in the current financing plan. Verisma has already used a transaction to expand the organization serving providers and requestors.

The company says it serves more than 20,000 clients across 50 states, a company-reported measure of reach. It does not disclose revenue, profitability, valuation or a new financing total in the announcement. Those omissions leave the commercial analysis focused on the operating scope and stated investment plan, without turning an undisclosed credit package into an invented growth scorecard.

For healthcare IT and information-management leaders, consolidation can change who answers for a larger collection of services. A broader supplier relationship brings the opportunity to coordinate more work through one organization, while making the quality of its internal handoffs more consequential. The record may pass between software products and service teams even when the customer sees one company name. DevCuration's coverage of Midstream Health's hospital financial operations software, Atlas Health's patient affordability business and SpendRule's contract enforcement offers adjacent examples of technology being sold around healthcare's administrative work. Verisma's own assignment centers on the information moving through that work.

McKenna's next phase of expansion therefore carries an assignment that reaches into the organizations Verisma serves. As new capabilities join the platform, somebody still has to locate the relevant history, follow the client's rules and put the next piece of work in front of the right person. Golub's financing supports the company taking on more of that responsibility across a healthcare system whose information was created long before its current software arrived.